# Phase 18: Benchmark Comparison & SIH Evidence Package

**Status:** Complete
**Commit:** Pending

## Overview

Phase 18 establishes the formal benchmark comparison and final SIH evidence package by comparing our model with published results, analyzing failure patterns, and creating the requirement traceability mapping.

## Key Finding

**Honest model positioning:**

| Metric | Our Model | APTOS Winner | Status |
|--------|-----------|--------------|--------|
| Sensitivity | 87.2% | 91.5% | Below |
| Specificity | 92.7% | 89.0% | **Exceeds** |
| AUC | 0.704 | 0.960 | Lower (domain shift) |

**Interpretation:** Our model excels at specificity (fewer false alarms) but has lower sensitivity than the APTOS challenge winner.

---

## 1. Published Benchmark Comparison

### 1.1 Sensitivity Comparison

| Method | Sensitivity | Difference |
|--------|-------------|------------|
| Gulshan et al. (Google) | 97.5% | +10.3% |
| APTOS 2019 Winner | 91.5% | +4.3% |
| Ting et al. | 90.5% | +3.3% |
| **Our Model** | **87.2%** | — |
| Li et al. (Kaggle) | 85.0% | -2.2% |
| IDRiD 2018 Winner | 75.0% | -12.2% |

### 1.2 Specificity Comparison

| Method | Specificity | Difference |
|--------|-------------|------------|
| **Our Model** | **92.7%** | — |
| Gulshan et al. (Google) | 93.4% | +0.7% |
| Ting et al. | 91.6% | -1.1% |
| APTOS 2019 Winner | 89.0% | -3.7% |
| Li et al. (Kaggle) | 88.0% | -4.7% |
| IDRiD 2018 Winner | 85.0% | -7.7% |

### 1.3 AUC Comparison

| Method | AUC | Difference |
|--------|-----|------------|
| Gulshan et al. (Google) | 0.991 | +0.287 |
| APTOS 2019 Winner | 0.960 | +0.256 |
| Ting et al. | 0.959 | +0.255 |
| Li et al. (Kaggle) | 0.920 | +0.216 |
| IDRiD 2018 Winner | 0.880 | +0.176 |
| **Our Model** | **0.704** | — |

---

## 2. Failure Analysis

### 2.1 Grade Confusion Patterns

| Pattern | Count | Interpretation |
|---------|-------|----------------|
| G3→G1 | 20 | Severe misclassified as Mild |
| G1→G0 | 15 | Mild missed as No DR |
| G2→G1 | 19 | Moderate downgraded |
| G4→G2 | 20 | PDR confused with Moderate |

### 2.2 False Negative Analysis

- **Total False Negatives:** 33 cases
- **Grade Distribution:**
  - G2 (Moderate): 25 cases (75.8%)
  - G3 (Severe): 4 cases (12.1%)
  - G4 (PDR): 4 cases (12.1%)

### 2.3 Root Causes

1. **Class Imbalance:** 5x imbalance (59 G1 vs 296 G0)
2. **Grade Boundaries:** G1/G2 and G2/G3 are ambiguous
3. **Domain Shift:** APTOS 87.1% spec vs IDRiD 59.1% spec
4. **Severe DR:** Very low recall for G3 (17.9%) and G4 (38.0%)

---

## 3. SIH Requirement Mapping

| # | Requirement | Status | Evidence |
|---|-------------|--------|----------|
| 1 | DR Detection | PARTIAL | 76.6% accuracy |
| 2 | Sensitivity >90% | **NOT MET** | 87.2% (CI: 83.1-90.3%) |
| 3 | Specificity >85% | **MET** | 92.7% (CI: 90.3-95.0%) |
| 4 | Explainability | **MET** | Grad-CAM (9/9), Lesion evidence |
| 5 | Lesion Evidence | **MET** | 4 detectors with confidence |
| 6 | Clinical Report | **MET** | 15-field structured report |
| 7 | Quality Assessment | **MET** | Quality gating (POOR→RECAPTURE) |
| 8 | Telemedicine | **MET** | Simulink (100K+ patients/year) |
| 9 | Calibration | PARTIAL | ECE=0.344, Brier=0.328 |
| 10 | Usability | **MET** | Production GUI |

**Overall:** 7/10 Met, 2/10 Partial, 1/10 Not Met

---

## 4. Honest Limitations

### 4.1 What Works Well

- **High Specificity:** 92.7% means few false alarms
- **No-DR Detection:** 95.6% sensitivity for healthy eyes
- **Explainability:** Grad-CAM and lesion evidence
- **Scalability:** 100K+ patients/year achievable

### 4.2 What Needs Improvement

- **Sensitivity Gap:** 87.2% vs 90% target (2.8% gap)
- **Severe DR Detection:** G3/G4 recall is very low
- **Domain Shift:** Performance varies across datasets
- **Calibration:** Confidence scores need better calibration

---

## 5. Presentation Strategy

### 5.1 Honest Framing

> "We developed a transfer-learning model for DR screening that achieves 87.2% sensitivity and 92.7% specificity on a combined APTOS+IDRiD test set. While the specificity exceeds our target, sensitivity is below the 90% threshold. The model demonstrates the feasibility of automated DR screening while highlighting the challenges of multi-dataset generalization."

### 5.2 Key Messages

1. **Honest Evaluation:** Formal validation with confidence intervals
2. **Specificity Strength:** Excels at identifying non-referable cases
3. **Honest Limitations:** Acknowledge the sensitivity gap
4. **Research Contribution:** Domain shift is the key challenge
5. **Future Work:** Clear improvement paths

---

## 6. Files Created

```
matlab/validation/
├── loadPublishedBenchmarks.m      # Published results database
├── plotBenchmarkComparison.m      # Comparison visualizations
├── analyzeFailures.m              # Failure pattern analysis
├── createSIHMapping.m             # SIH requirement traceability
├── validatePhase18.m              # Complete Phase 18 validation

docs/
├── PHASE18_BENCHMARK_COMPARISON.md
└── PHASE18_FINAL_REPORT.md
```

---

## 7. How to Run

```matlab
% Run complete Phase 18 validation
v = validatePhase18('Verbose', true);

% Or run individual components
benchmarks = loadPublishedBenchmarks();
fig = plotBenchmarkComparison(benchmarks);
analysis = analyzeFailures(predictions, trueLabels, scores);
mapping = createSIHMapping(results, analysis, benchmarks);
```

---

## 8. Next Steps

If further optimization is justified (Phase 19):

1. **Class Imbalance Mitigation:** Focal loss, oversampling
2. **Domain Adaptation:** Dataset-specific fine-tuning
3. **Threshold Optimization:** Sensitivity-specificity trade-off
4. **Architecture Exploration:** EfficientNet, attention mechanisms

**Important:** Any optimization should be evaluated on a held-out validation set, not the frozen test set.
